ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
133.009,78
1,08%
S&P 500
5.745,37
0,40%
US Dollar vs BRL
5,4408
0,05%
Bitcoin
65.596,93
0,63%
Brent Oil
71,295
0,49%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. PureTech Health PLC (PRTC)

  7. PureTech Health PLC (PRTC) Notícias

PRTC

PureTech Health (PRTC)

PureTech Health PLC
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:PRTC
DataHoraFonteTítuloCódigoCompanhia
27/09/202403:00Business WirePureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in AdultsNASDAQ:PRTCPureTech Health PLC
06/09/202403:00Business WirePureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted TherapiesNASDAQ:PRTCPureTech Health PLC
28/08/202417:31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTCPureTech Health PLC
28/08/202403:01Business WirePureTech Health plc – Half-Year ReportNASDAQ:PRTCPureTech Health PLC
22/08/202403:00Business WirePureTech Appoints Michele Holcomb, PhD, to Board of DirectorsNASDAQ:PRTCPureTech Health PLC
21/08/202403:00Business WirePureTech Health: Notice of Half-Yearly ResultsNASDAQ:PRTCPureTech Health PLC
13/08/202408:05Business WirePureTech Founded Entity Seaport Therapeutics Appoints David Wheadon, M.D., to its Board of DirectorsNASDAQ:PRTCPureTech Health PLC
23/07/202409:26Business WirePureTech Founded Entity Vedanta Biosciences Expands Leadership Team and Appoints Head of CommercialNASDAQ:PRTCPureTech Health PLC
24/06/202413:00Business WirePureTech Health: Completion of Tender Offer & Total Voting RightsNASDAQ:PRTCPureTech Health PLC
24/06/202403:00Business WirePureTech Health: Results of the Tender OfferNASDAQ:PRTCPureTech Health PLC
20/06/202403:00Business WirePureTech Announces Change of Board RoleNASDAQ:PRTCPureTech Health PLC
18/06/202408:05Business WirePureTech Founded Entity Seaport Therapeutics Appoints Seasoned Executives to Management TeamNASDAQ:PRTCPureTech Health PLC
13/06/202414:15Business WirePureTech Health: Results of Annual General MeetingNASDAQ:PRTCPureTech Health PLC
06/06/202417:39Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:PRTCPureTech Health PLC
06/06/202413:38Business WirePureTech Health: Result of General MeetingNASDAQ:PRTCPureTech Health PLC
30/05/202409:05Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:PRTCPureTech Health PLC
29/05/202409:09Business WirePureTech Founded Entity Akili Interactive and Virtual Therapeutics Announce Entering Into Definitive Merger Agreement to Establish Leading Digital Health CompanyNASDAQ:PRTCPureTech Health PLC
23/05/202408:00Business WirePureTech to Present at the Jefferies Global Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
21/05/202408:05Business WirePureTech Founded Entity Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile InfectionNASDAQ:PRTCPureTech Health PLC
20/05/202408:03Edgar (US Regulatory)Form SC TO-I - Tender offer statement by IssuerNASDAQ:PRTCPureTech Health PLC
20/05/202403:00Business WirePureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary ShareNASDAQ:PRTCPureTech Health PLC
09/05/202408:05Business WirePureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual MeetingNASDAQ:PRTCPureTech Health PLC
07/05/202408:05Business WirePureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive AppointmentsNASDAQ:PRTCPureTech Health PLC
25/04/202406:22Business WirePureTech Announces Annual Results for Year Ended December 31, 2023NASDAQ:PRTCPureTech Health PLC
18/04/202403:00Business WirePureTech Health: Notice of ResultsNASDAQ:PRTCPureTech Health PLC
16/04/202408:00Business WirePureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary FibrosisNASDAQ:PRTCPureTech Health PLC
11/04/202408:00Business WirePureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck CancersNASDAQ:PRTCPureTech Health PLC
09/04/202403:00Business WirePureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management TransitionsNASDAQ:PRTCPureTech Health PLC
19/03/202404:00Business WirePureTech Proposes $100 Million Capital ReturnNASDAQ:PRTCPureTech Health PLC
18/03/202410:52Business WireBristol Myers Squibb Completes Acquisition of PureTech's Founded Entity Karuna Therapeutics for $14 BillionNASDAQ:PRTCPureTech Health PLC
 Apresentando as notícias mais relevantes sobre:NASDAQ:PRTC

Seu Histórico Recente

BOV
PRIO3
PETRORIO ON
BOV
IBOV
Índice Bovespa
BOV
PDGR3
PDG REALT ON
BOV
CBEE3
AMPLA ENERG ON
BOV
TELB4
TELEBRAS PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados